BridgeMD
New treatment option for Dysglycemia
Official title Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values
ClinicalTrials.gov ID: NCT07263789
What this study is testing
- What it's testing
- The primary objective is to evaluate the efficacy of Euglycem® plus recommended standard diet on reducing FPG compared to baseline and to recommended standard diet alone after 3 months
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- BMI ≤30 kg/m2
- people able to understand the informed consent and sign it before enrollment in the study
- people willing to follow all study requirements and perform all study visits as well as collaborate with the investigator.
You likely can't join if
- ongoing treatment with drugs that can affect blood glucose
- current participation in another investigational drug or investigational device trial or inclusion in another investigational drug or investigational...
The study team makes the final eligibility decision.
Where it's taking place
- Pavia, Lombardy, Italy
- Pavia, Pavia, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pavia, Lombardy, Italy; Pavia, Pavia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.